Suchergebnisse - "Galluzzo, Marco"

PubPharm (11)

1

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis : 42-Month Results from the SUPREME 2.0 Study

enthalten in: Clinical, cosmetic and investigational dermatology | 2023

von Russo, F. | Galluzzo, M. | Stingeni, L. | +40

2

Secukinumab for the treatment of palmoplantar psoriasis : a 2-year, multicenter, real-life observational study

enthalten in: Expert opinion on biological therapy | 2022

von Galluzzo, M. | Talamonti, M. | Atzori, L. | +12

3

Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis : Results from the SUPREME Study

enthalten in: Acta dermato-venereologica | 2021

von Costanzo, A. | Russo, F. | Galluzzo, M. | +30

4

HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis

enthalten in: Expert opinion on biological therapy | 2021

von Morelli, M. | Galluzzo, M. | Madonna, S. | +9

5

Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis : a review of clinical studies

enthalten in: Expert opinion on biological therapy | 2021

von Galluzzo, M. | Talamonti, M. | Manfreda, V. | +5

6

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | Tofani, L. | Bianchi, L. | +1

7

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | D'Adamio, S. | Silvaggio, D. | +3

8

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : results from extension phase of the SUPREME study

enthalten in: The British journal of dermatology | 2019

von Papini, M. | Cusano, F. | Romanelli, M. | +58

9

Biologic therapy for acrodermatitis continua of Hallopeau : Successful treatment with secukinumab and review of the literature

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Teoli, M. | +2

10

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : SUPREME study

enthalten in: The British journal of dermatology | 2018

von Costanzo, A. | Bianchi, L. | Flori, M. | +53